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Two patients samples were used (B1 and B2). The viral RNA 
from the patients samples were extracted by RNAeasy 
microkit made by QIAGEN following the manufacturer’s 
protocol. PCR reaction was set up to amplify the target 
regions (NEP and NS1 protein) of the viral genome using the 
designed primers and gel electrophoresis was done to 
confirm that we have the desired target region of 103 bp size 
fragment successfully amplified. Using pCR 4-TOPO cloning 
kit from Invitrogen®, the target fragment was cloned into the 
vector and incorporated into competent cells and plated on 
ampicillin coated platform. Next, M13 PCR and patch plate 
was to be performed the to determine which colony had the 
right size fragment inserted in it and followed by gel 
electrophoresis as confirmation. Based on the gel 
electrophoresis result, transformants are selected and 
cultured in LB broth and the genetic material is then extracted 
from the transformants. Nanodrop measurement is performed 
in order to measure the concentration of genetic material in 
the extraction. Finally the extraction containing the target 
genome sequence is sent off for sequencing to a lab in San 
Francisco.  
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Influenza viruses cause seasonal epidemics associated with high 
morbidity, especially in immunocompromised and extreme age 
group individuals. Many strategies for combating these viruses 
are in practice;  however, developing and maintaining sensitive 
and specific diagnostic method is essential to the success of 
strategies used. The purpose of this project is to clone a 
diagnostic gene for Influenza B virus and create e.coli colony 
type that we can propagate as needed for future test validations 
at the State Virology Laboratory in Fairbanks, AK.  
Influenza B is a linear single-stranded negative sense RNA virus 
with a total genome length of 13.5kb. It causes disease only in 
humans and seals. Its virions are enveloped and can either be 
quasi-spherical or filamentous. It has 8 gene segments that codes 
for 11 viral protein. Envelope is derived from host cell plasma 
membrane and it has a compact helical nucleocapsid. The virus 
attaches to sialic acid receptor through HA (hemagglutinin) protein 
and fuses with the host cell membrane via clathrin dependent 
endocytosis(1). Molecular diagnostic assays using PCR method 
most often targets regions of the genome that are highly conserved. 
In this project,  we targeted the nuclear export protein( NEP) and 
non-structural protein 1( NSP1) in gene segment 8. This target of 
103 bp region is found among all influenza B viral strains that are 
known to have infected human(2).  
Results  
Gel electrophoresis result showed that viral RNA extracted from 
patient 2 (designated as B2) was successfully amplified by 
PCR. However, the PCR reaction did not work for patient 1 
sample.  
 
 
 
 
 
 
 
 
 
 
 
   
The project consisted of sequence of steps and the following 
flow chart outlines the complete process.  
Extraction of viral RNA PCR Gel Electrophoresis  
Clone into vector   M13 PCR & Patch Plate Gel 
Electrophoresis Culture transformants in LB broth 
Extract DNA from transformants Concentration 
Measurement (Nanodrop) Send for sequencing 
Methods (cont.d) 
Figure 1. Result from gel 
electrophoresis on PCR 
amplified product of 
target sequence coding 
for proteins NEP and 
NS1. Target fragment 
size is 103 bp.   
Results (cont.d) 
Once the PCR product containing the right target sequence 
was obtained, here had been multiple attempts at cloning the 
desired the target genes. However, due to several technical 
issues we have encountered, none of the cloning attempts 
were successful. Therefore, the rest of the steps were halted, 
which are M13 PCR and patch plate, selection and culturing of 
transformants, extraction and sequencing of genetic materials 
from the bacterial colony.   
Developing and replicating a reliable molecular diagnostic 
assay is not an easy task. There are various number of things 
that could go wrong at every stage of the process and yet 
there are many areas where it also needs to be optimized 
through trial and error. Cloning of the target genes involves 
number of steps. First step is a ligation reaction of PCR 
product with the TOPO vector plasmid bathed in a salt 
solution. The usage of salt solution was experimentally shown 
to increase the yield of ligated product. However, using highly 
concentrated salt solution would jeopardize the next step of 
the process, which is electroporation of the competent cells. 
After the ligation reaction, the ligated vector containing target 
gene is mixed with competent cells and the vectors are 
inserted through holes made in cell membrane by treating 
them electrically using an electroporator. One of the possible 
explanations for our failed cloning experiment could be non- 
optimized concentration of salt solution used.  
